SG11201609211VA - Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same - Google Patents

Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same

Info

Publication number
SG11201609211VA
SG11201609211VA SG11201609211VA SG11201609211VA SG11201609211VA SG 11201609211V A SG11201609211V A SG 11201609211VA SG 11201609211V A SG11201609211V A SG 11201609211VA SG 11201609211V A SG11201609211V A SG 11201609211VA SG 11201609211V A SG11201609211V A SG 11201609211VA
Authority
SG
Singapore
Prior art keywords
nucleic acid
same
modification method
molecular complex
acid bases
Prior art date
Application number
SG11201609211VA
Inventor
Keiji Nishida
Akihiko Kondo
Satomi Kojima
Original Assignee
Nat Univ Corp Univ Kobe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54055356&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201609211V(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nat Univ Corp Univ Kobe filed Critical Nat Univ Corp Univ Kobe
Publication of SG11201609211VA publication Critical patent/SG11201609211VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • C12N15/1024In vivo mutagenesis using high mutation rate "mutator" host strains by inserting genetic material, e.g. encoding an error prone polymerase, disrupting a gene for mismatch repair
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/04Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
    • C12Y305/04005Cytidine deaminase (3.5.4.5)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/80Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3513Protein; Peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG11201609211VA 2014-03-05 2015-03-04 Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same SG11201609211VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014043348 2014-03-05
JP2014201859 2014-09-30
PCT/JP2015/056436 WO2015133554A1 (en) 2014-03-05 2015-03-04 Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same

Publications (1)

Publication Number Publication Date
SG11201609211VA true SG11201609211VA (en) 2016-12-29

Family

ID=54055356

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201609211VA SG11201609211VA (en) 2014-03-05 2015-03-04 Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same

Country Status (11)

Country Link
US (3) US10655123B2 (en)
EP (2) EP3115457B1 (en)
JP (5) JP6206893B2 (en)
CN (5) CN111500569A (en)
CA (1) CA2947941C (en)
DK (1) DK3115457T3 (en)
ES (1) ES2752175T3 (en)
PL (1) PL3115457T3 (en)
PT (1) PT3115457T (en)
SG (1) SG11201609211VA (en)
WO (1) WO2015133554A1 (en)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012088381A2 (en) 2010-12-22 2012-06-28 President And Fellows Of Harvard College Continuous directed evolution
EP3613852A3 (en) 2011-07-22 2020-04-22 President and Fellows of Harvard College Evaluation and improvement of nuclease cleavage specificity
EP2920319B1 (en) 2012-11-16 2020-02-19 Poseida Therapeutics, Inc. Site-specific enzymes and methods of use
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US9737604B2 (en) 2013-09-06 2017-08-22 President And Fellows Of Harvard College Use of cationic lipids to deliver CAS9
US20150166982A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting pi3k point mutations
EP3115457B1 (en) 2014-03-05 2019-10-02 National University Corporation Kobe University Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
CA2952613A1 (en) * 2014-06-17 2015-12-23 Poseida Therapeutics, Inc. A method for directing proteins to specific loci in the genome and uses thereof
WO2016022363A2 (en) 2014-07-30 2016-02-11 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
US10920208B2 (en) 2014-10-22 2021-02-16 President And Fellows Of Harvard College Evolution of proteases
WO2016072399A1 (en) * 2014-11-04 2016-05-12 国立大学法人神戸大学 Method for modifying genome sequence to introduce specific mutation to targeted dna sequence by base-removal reaction, and molecular complex used therein
US11299729B2 (en) 2015-04-17 2022-04-12 President And Fellows Of Harvard College Vector-based mutagenesis system
CN108026519A (en) 2015-06-17 2018-05-11 波赛达治疗公司 The composition and method for particular locus protein being directed in genome
WO2017011721A1 (en) * 2015-07-15 2017-01-19 Rutgers, The State University Of New Jersey Nuclease-independent targeted gene editing platform and uses thereof
WO2017015545A1 (en) 2015-07-22 2017-01-26 President And Fellows Of Harvard College Evolution of site-specific recombinases
US11524983B2 (en) 2015-07-23 2022-12-13 President And Fellows Of Harvard College Evolution of Bt toxins
WO2017019895A1 (en) 2015-07-30 2017-02-02 President And Fellows Of Harvard College Evolution of talens
DK3348638T3 (en) * 2015-09-09 2023-02-13 Univ Kobe Nat Univ Corp METHOD OF CONVERTING GENOME SEQUENCE FROM GRAM-POSITIVE BACTERIA BY SPECIFICALLY CONVERTING NUCLEIC ACID BASE INTO THE INTENDED DNA SEQUENCE, AND MOLECULAR COMPLEX USED THEREFOR
GB2559922A (en) * 2015-10-23 2018-08-22 Harvard College Nucleobase editors and uses thereof
JP7109784B2 (en) * 2015-10-23 2022-08-01 プレジデント アンド フェローズ オブ ハーバード カレッジ Evolved Cas9 protein for gene editing
CA3005968A1 (en) 2015-11-23 2017-06-01 The Regents Of The University Of California Tracking and manipulating cellular rna via nuclear delivery of crispr/cas9
ES2914623T3 (en) * 2015-11-27 2022-06-14 Univ Kobe Nat Univ Corp Method for converting a genomic sequence of a monocot plant in which a nucleic acid base in the target DNA sequence is specifically converted and the molecular complex used therein
CA3021281C (en) * 2016-04-21 2021-07-27 National University Corporation Kobe University Method for increasing mutation introduction efficiency in genome sequence modification technique, and molecular complex to be used therefor
CA3022319A1 (en) * 2016-05-06 2017-11-09 Tod M. Woolf Improved methods for genome editing with and without programmable nucleases
WO2017195905A1 (en) 2016-05-13 2017-11-16 株式会社カネカ Method for creating transformed plant
US11499158B2 (en) 2016-05-13 2022-11-15 Kaneka Corporation Method for modifying plant
JP2017205104A (en) * 2016-05-13 2017-11-24 株式会社カネカ Method for editing genome of plant
WO2017215619A1 (en) * 2016-06-15 2017-12-21 中国科学院上海生命科学研究院 Fusion protein producing point mutation in cell, and preparation and use thereof
WO2018010516A1 (en) * 2016-07-13 2018-01-18 陈奇涵 Method for specifically editing genomic dna and application thereof
CN106086061A (en) * 2016-07-27 2016-11-09 苏州泓迅生物科技有限公司 A kind of genes of brewing yeast group editor's carrier based on CRISPR Cas9 system and application thereof
CN106191099A (en) * 2016-07-27 2016-12-07 苏州泓迅生物科技有限公司 A kind of parallel multiple editor's carrier of genes of brewing yeast group based on CRISPR Cas9 system and application thereof
WO2018027078A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
JP2019524162A (en) * 2016-08-18 2019-09-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア CRISPR-Cas genome editing with modular AAV delivery system
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
WO2018071868A1 (en) 2016-10-14 2018-04-19 President And Fellows Of Harvard College Aav delivery of nucleobase editors
AR110075A1 (en) * 2016-11-14 2019-02-20 Inst Genetics & Developmental Biology Cas A METHOD FOR BASIC EDITION IN PLANTS
CN107043779B (en) * 2016-12-01 2020-05-12 中国农业科学院作物科学研究所 Application of CRISPR/nCas 9-mediated site-specific base substitution in plants
US20180237787A1 (en) * 2016-12-23 2018-08-23 President And Fellows Of Harvard College Gene editing of pcsk9
JP2020504612A (en) * 2016-12-23 2020-02-13 インスティテュート フォー ベーシック サイエンスInstitute For Basic Science Animal embryo base editing composition and base editing method
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
JP7219972B2 (en) 2017-01-05 2023-02-09 ラトガース,ザ ステート ユニバーシティ オブ ニュー ジャージー DNA double-strand break-independent targeted gene editing platform and its applications
JP2020505062A (en) * 2017-01-17 2020-02-20 インスティテュート フォー ベーシック サイエンスInstitute For Basic Science Base editing non-target position confirmation method by DNA single strand break
JPWO2018143477A1 (en) * 2017-02-06 2019-04-25 国立大学法人 筑波大学 Method of modifying genome of dicotyledonous plant
WO2018149915A1 (en) * 2017-02-15 2018-08-23 Keygene N.V. Methods of targeted genetic alteration in plant cells
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
KR20190127797A (en) 2017-03-10 2019-11-13 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Cytosine to Guanine Base Editing Agent
CN110446782B (en) * 2017-03-22 2024-03-01 国立大学法人神户大学 Method for changing target site of DNA of cell and complex for the method
CA3057192A1 (en) 2017-03-23 2018-09-27 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
CA3058453A1 (en) 2017-03-31 2018-10-04 Pioneer Hi-Bred International, Inc. Expression modulating elements and use thereof
EP3635118A4 (en) * 2017-05-05 2021-01-27 Institute Of Genetics And Developmental Biology Chinese Academy of Sciences Methods for isolating cells without the use of transgenic marker sequences
CA3062595A1 (en) * 2017-05-10 2018-11-15 The Regents Of The University Of California Directed editing of cellular rna via nuclear delivery of crispr/cas9
CN108866092B (en) * 2017-05-11 2022-12-27 中国科学院遗传与发育生物学研究所 Production of herbicide-resistant genes and uses thereof
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
WO2018225807A1 (en) * 2017-06-07 2018-12-13 国立大学法人東京大学 Gene therapy for granular corneal dystrophy
WO2019010164A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College Evolution of trna synthetases
US11732274B2 (en) 2017-07-28 2023-08-22 President And Fellows Of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
EA201992615A1 (en) * 2017-09-01 2020-03-10 Институте Оф Генетисс Анд Девелопментал Биологй, Чинесе Асадемй Оф Ссиенсес METHODS FOR ISOLATING CELLS WITHOUT USING TRANSGENIC MARKER SEQUENCES
US11624130B2 (en) 2017-09-18 2023-04-11 President And Fellows Of Harvard College Continuous evolution for stabilized proteins
CA3082251A1 (en) 2017-10-16 2019-04-25 The Broad Institute, Inc. Uses of adenosine base editors
US20200332272A1 (en) * 2017-10-23 2020-10-22 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
CN111615557A (en) 2017-11-22 2020-09-01 国立大学法人神户大学 Stable genome editing complex with few side effects and nucleic acid encoding same
JP7075170B2 (en) * 2018-01-23 2022-05-25 インスティチュート フォー ベーシック サイエンス Extended single guide RNA and its uses
US11041169B2 (en) 2018-03-26 2021-06-22 National University Corporation Kobe University Method for modifying target site in double-stranded DNA in cell
WO2019234132A1 (en) 2018-06-05 2019-12-12 KWS SAAT SE & Co. KGaA Base editing in polymerase theta deficient plants
WO2019241649A1 (en) 2018-06-14 2019-12-19 President And Fellows Of Harvard College Evolution of cytidine deaminases
KR20210041008A (en) * 2018-08-03 2021-04-14 빔 테라퓨틱스, 인크. Multi-effector nucleobase editor for modifying nucleic acid target sequences and methods of using the same
JP2021533742A (en) * 2018-08-07 2021-12-09 株式会社モダリス New transcription activator
JP7402453B2 (en) * 2018-08-13 2023-12-21 Spiber株式会社 Methods of isolating or identifying cells and cell populations
AU2019326408A1 (en) * 2018-08-23 2021-03-11 Sangamo Therapeutics, Inc. Engineered target specific base editors
WO2020051561A1 (en) * 2018-09-07 2020-03-12 Beam Therapeutics Inc. Compositions and methods for delivering a nucleobase editing system
CA3118340A1 (en) 2018-11-01 2020-05-07 KWS SAAT SE & Co. KGaA Targeted mutagenesis using base editors
CA3124395A1 (en) 2018-12-20 2020-06-25 Basf Plant Science Company Gmbh Native delivery of biomolecules into plant cells using ionic complexes with cell-penetrating peptides
MX2021011426A (en) 2019-03-19 2022-03-11 Broad Inst Inc Methods and compositions for editing nucleotide sequences.
CA3138329A1 (en) 2019-05-10 2020-11-19 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
US20220333133A1 (en) 2019-09-03 2022-10-20 Voyager Therapeutics, Inc. Vectorized editing of nucleic acids to correct overt mutations
EP4028530A1 (en) 2019-09-12 2022-07-20 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
WO2021069387A1 (en) 2019-10-07 2021-04-15 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
CA3159805A1 (en) 2019-12-03 2021-06-10 Frank Meulewaeter Regulatory nucleic acid molecules for enhancing gene expression in plants
US11867043B1 (en) 2019-12-13 2024-01-09 Klx Energy Services Llc Remotely-controlled pressure bleed-off system
US20230042273A1 (en) 2019-12-16 2023-02-09 BASF Agricultural Solutions Seed US LLC Improved genome editing using paired nickases
CN114846144A (en) 2019-12-16 2022-08-02 巴斯夫农业种子解决方案美国有限责任公司 Accurate introduction of DNA or mutations into wheat genome
WO2021175759A1 (en) 2020-03-04 2021-09-10 Basf Se Method for the production of constitutive bacterial promoters conferring low to medium expression
WO2021175756A1 (en) 2020-03-04 2021-09-10 Basf Se Shuttle vector for expression in e. coli and bacilli
WO2021183622A1 (en) 2020-03-12 2021-09-16 Novozymes A/S Crispr-aid using catalytically inactive rna-guided endonuclease
IL297761A (en) 2020-05-08 2022-12-01 Broad Inst Inc Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
AU2021272383A1 (en) 2020-05-15 2022-12-08 Basf Se Improved method for the production of isoprenoids
WO2021250058A2 (en) 2020-06-12 2021-12-16 Bayer Aktiengesellschaft CRISPR-Cas12a DIRECTED RANDOM MUTAGENESIS AGENTS AND METHODS
EP4209589A1 (en) 2020-09-04 2023-07-12 National University Corporation Kobe University Miniaturized cytidine deaminase-containing complex for modifying double-stranded dna
EP4299738A1 (en) 2021-02-26 2024-01-03 National University Corporation Kobe University Semi-rational genome evolution engineering method for plants
WO2023118136A1 (en) 2021-12-22 2023-06-29 BASF Agricultural Solutions Seed US LLC Improved screening method for genome edited events

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1017829A2 (en) * 1997-08-26 2000-07-12 Ariad Gene Therapeutics, Inc. Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
US8106255B2 (en) 2002-01-23 2012-01-31 Dana Carroll Targeted chromosomal mutagenasis using zinc finger nucleases
CA2506999C (en) * 2002-12-02 2014-01-07 Basf Aktiengesellschaft L-rhamnose-inducible expression systems
WO2007139573A1 (en) * 2006-05-31 2007-12-06 The Trustees Of Columbia University In The City Of New York Ribosome and rna display of biologically active small molecules
WO2008059317A1 (en) * 2006-11-14 2008-05-22 Cellectis Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
DK2860267T3 (en) 2007-03-02 2019-04-23 Dupont Nutrition Biosci Aps CULTURES WITH IMPROVED PROFESS RESISTANCE
WO2010132092A2 (en) * 2009-05-12 2010-11-18 The Scripps Research Institute Cytidine deaminase fusions and related methods
US8772008B2 (en) 2009-05-18 2014-07-08 Sangamo Biosciences, Inc. Methods and compositions for increasing nuclease activity
US20110104787A1 (en) * 2009-11-05 2011-05-05 President And Fellows Of Harvard College Fusion Peptides That Bind to and Modify Target Nucleic Acid Sequences
PL2510096T5 (en) 2009-12-10 2018-06-29 Regents Of The University Of Minnesota Tal effector-mediated dna modification
JP2013128413A (en) 2010-03-11 2013-07-04 Kyushu Univ Method for modifying rna-binding protein using ppr motif
US9512444B2 (en) * 2010-07-23 2016-12-06 Sigma-Aldrich Co. Llc Genome editing using targeting endonucleases and single-stranded nucleic acids
AU2012326971C1 (en) 2011-10-21 2018-02-08 Kyushu University, National University Corporation Method for designing RNA binding protein utilizing PPR motif, and use thereof
GB201122458D0 (en) 2011-12-30 2012-02-08 Univ Wageningen Modified cascade ribonucleoproteins and uses thereof
EP2828384B1 (en) * 2012-03-23 2018-05-09 Cellectis Method to overcome dna chemical modifications sensitivity of engineered tale dna binding domains
RU2650819C2 (en) 2012-05-07 2018-04-17 Сангамо Терапьютикс, Инк. Methods and compositions for nuclease-mediated targeting of transgenes
EA038924B1 (en) * 2012-05-25 2021-11-10 Те Риджентс Оф Те Юниверсити Оф Калифорния Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
CN116622704A (en) * 2012-07-25 2023-08-22 布罗德研究所有限公司 Inducible DNA binding proteins and genomic disruption tools and uses thereof
DE102012016854A1 (en) 2012-08-25 2014-02-27 Saurer Germany Gmbh & Co. Kg Method of connecting coil with winding at winding station of winding machine, involves inserting upper thread into thread link assembly, if tubular connector of suction nozzle is in thread insertion position
US20150315576A1 (en) 2012-11-01 2015-11-05 Massachusetts Institute Of Technology Genetic device for the controlled destruction of dna
WO2014089406A1 (en) 2012-12-07 2014-06-12 The United States Of America, As Represented By The Secretary,Department Of Health & Human Services Device and method for detection of counterfeit pharmaceuticals and/or drug packaging
EP4234696A3 (en) 2012-12-12 2023-09-06 The Broad Institute Inc. Crispr-cas component systems, methods and compositions for sequence manipulation
CN113528577A (en) 2012-12-12 2021-10-22 布罗德研究所有限公司 Engineering of systems, methods and optimized guide compositions for sequence manipulation
US8697359B1 (en) * 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
EP2981166B1 (en) * 2013-04-05 2020-09-09 Dow AgroSciences LLC Methods and compositions for integration of an exogenous sequence within the genome of plants
JP2014201859A (en) 2013-04-08 2014-10-27 旭化成せんい株式会社 Deodorant antibacterial fiber fabric excellent in durability
WO2014186686A2 (en) 2013-05-17 2014-11-20 Two Blades Foundation Targeted mutagenesis and genome engineering in plants using rna-guided cas nucleases
US11414695B2 (en) 2013-05-29 2022-08-16 Agilent Technologies, Inc. Nucleic acid enrichment using Cas9
US20150044772A1 (en) * 2013-08-09 2015-02-12 Sage Labs, Inc. Crispr/cas system-based novel fusion protein and its applications in genome editing
US9737604B2 (en) 2013-09-06 2017-08-22 President And Fellows Of Harvard College Use of cationic lipids to deliver CAS9
DE102013222278A1 (en) * 2013-11-01 2015-05-07 Tesa Se Reactive 2-component adhesive system
US20150166982A1 (en) * 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting pi3k point mutations
EP3115457B1 (en) 2014-03-05 2019-10-02 National University Corporation Kobe University Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
JP6879910B2 (en) 2014-10-31 2021-06-02 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Modification of gene expression in CART cells and their use
WO2016072399A1 (en) 2014-11-04 2016-05-12 国立大学法人神戸大学 Method for modifying genome sequence to introduce specific mutation to targeted dna sequence by base-removal reaction, and molecular complex used therein
CA2998087A1 (en) 2015-09-09 2017-03-16 National University Corporation Kobe University Method for modifying genome sequence that specifically converts nucleobase of targeted dna sequence, and molecular complex used in said method
JP7109784B2 (en) 2015-10-23 2022-08-01 プレジデント アンド フェローズ オブ ハーバード カレッジ Evolved Cas9 protein for gene editing
ES2914623T3 (en) 2015-11-27 2022-06-14 Univ Kobe Nat Univ Corp Method for converting a genomic sequence of a monocot plant in which a nucleic acid base in the target DNA sequence is specifically converted and the molecular complex used therein

Also Published As

Publication number Publication date
CA2947941C (en) 2021-02-23
CN106459957B (en) 2020-03-20
CN111471675A (en) 2020-07-31
ES2752175T3 (en) 2020-04-03
PL3115457T3 (en) 2020-01-31
JP2020167998A (en) 2020-10-15
US20200208138A1 (en) 2020-07-02
US10655123B2 (en) 2020-05-19
US11718846B2 (en) 2023-08-08
CA2947941A1 (en) 2015-09-11
EP3613854A1 (en) 2020-02-26
CN111500569A (en) 2020-08-07
JPWO2015133554A1 (en) 2017-04-06
DK3115457T3 (en) 2019-11-04
CN106459957A (en) 2017-02-22
EP3115457B1 (en) 2019-10-02
JP2018019705A (en) 2018-02-08
JP2022191368A (en) 2022-12-27
WO2015133554A1 (en) 2015-09-11
US20170073670A1 (en) 2017-03-16
US20200248174A1 (en) 2020-08-06
JP6206893B2 (en) 2017-10-04
CN111471674A (en) 2020-07-31
EP3115457A4 (en) 2017-08-09
JP2018201513A (en) 2018-12-27
EP3115457A1 (en) 2017-01-11
JP6462069B2 (en) 2019-01-30
PT3115457T (en) 2019-11-05
CN111500570A (en) 2020-08-07

Similar Documents

Publication Publication Date Title
SG11201609211VA (en) Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
HK1253544A1 (en) Method for converting genome sequence of gram-positive bacterium by specifically converting nucleic acid base of targeted dna sequence, and molecular complex used in same
HK1253540A1 (en) Method for modifying genome sequence that specifically converts nucleobase of targeted dna sequence, and molecular complex used in said method
HK1256888A1 (en) Method for converting monocot plant genome sequence in which nucleic acid base in targeted dna sequence is specifically converted, and molecular complex used therein
IL288263A (en) Crispr hybrid dna/rna polynucleotides and methods of use
PL3216867T3 (en) Method for modifying genome sequence to introduce specific mutation to targeted dna sequence by base-removal reaction, and molecular complex used therein
IL259788A (en) Adapter nucleic acid sequences, compositions comprising same and methods for duplex sequencing using same
SG11201608503UA (en) Methods and compositions for modifying genomic dna
SG11201610707RA (en) Nucleic acid amplification device, nucleic acid amplification method, and chip for nucleic acid amplification
EP3192869A4 (en) Isolated oligonucleotide and use thereof in nucleic acid sequencing
ZA201801947B (en) Compounds as dna probes, methods and applications thereof
GB201407334D0 (en) Integrated nucleic acid test system, instrument and method
GB201509226D0 (en) Molecular and bioinformatics methods for direct sequencing
EP3102677A4 (en) Genomic dna extraction reagent and method
SG11201704744QA (en) Methods and kits for purifying plasmid dna
EP3103884A4 (en) Nucleic acid detection and assay method using mask oligonucleotide, and device for same
EP3124622A4 (en) Fluorescent labeled single-stranded nucleic acid and use thereof
EP3308789A4 (en) Nucleic acid delivery carrier, nucleic acid delivery kit, and nucleic acid delivery method
EP3124608A4 (en) Method and reagent for extracting nucleic acid
EP3231866A4 (en) Nucleic acid complex, method for forming nucleic acid hybridization, pharmaceutical composition, nucleic acid probe, and complementary-strand nucleic acid complex